FFA
AUPH icon

Farther Finance Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Farther Finance Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.4K Sell
2,222
-268
-11% -$3.92K ﹤0.01% 3258
2025
Q4 		$39.7K Buy
2,490
+425
+21% +$6.03K ﹤0.01% 2968
2025
Q3 		$22.8K Buy
2,065
+2,047
+11,372% +$22.4K ﹤0.01% 2954
2025
Q2 		$152 Hold
18
– – ﹤0.01% 4250
2025
Q1 		$145 Hold
18
– – ﹤0.01% 4011
2024
Q4 		$162 Sell
18
-10
-36% -$82 ﹤0.01% 3703
2024
Q3 		$205 Sell
28
-55
-66% -$341 ﹤0.01% 3645
2024
Q2 		$456 Buy
83
+68
+453% +$358 ﹤0.01% 3303
2024
Q1 		$81 Sell
15
-42
-74% -$285 ﹤0.01% 3413
2023
Q4 		$512 Buy
+57
New +$469 ﹤0.01% 2971

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return